Axonics Modulation Technologies Inc.

58.67-1.16-1.94%Vol 363.11K1Y Perf 70.52%
Apr 19th, 2021 16:00 DELAYED
BID56.51 ASK61.01
Open59.68 Previous Close59.83
Pre-Market- After-Market-
 - -  - -%
Target Price
65.89 
Analyst Rating
Strong Buy 1.13
Potential %
12.31 
Finscreener Ranking
★★★★     55.29
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     52.54
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     53.88
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap2.44B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
92.01 
Earnings Date
6th May 2021

Today's Price Range

57.8759.81

52W Range

30.0061.16

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
0.29%
1 Month
2.68%
3 Months
15.49%
6 Months
24.96%
1 Year
70.52%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AXNX58.67-1.1600-1.94
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Financial StrengthValueIndustryS&P 500US Markets
5.70
7.20
0.03
0.11
-28.30
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
60.20
-74.20
-72.40
-
-46.99
RevenueValueIndustryS&P 500US Markets
85.24M
2.05
925.77
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.32-0.299.38
Q03 2020-0.52-0.2453.85
Q02 2020-0.59-0.548.47
Q01 2020-0.56-0.4323.21
Q04 2019-0.64-0.75-17.19
Q03 2019-0.73-0.89-21.92
Q02 2019-0.51-0.68-33.33
Q01 2019-0.40-0.47-17.50
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.41-20.59Negative
6/2021 QR-0.35-6.06Negative
12/2021 FY-1.192.46Positive
12/2022 FY-0.3915.22Positive
Next Report Date6th May 2021
Estimated EPS Next Report-0.41
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume363.11K
Shares Outstanding41.52M
Trades Count4.76K
Dollar Volume47.84M
Avg. Volume553.32K
Avg. Weekly Volume361.36K
Avg. Monthly Volume443.43K
Avg. Quarterly Volume569.08K

Axonics Modulation Technologies Inc. (NASDAQ: AXNX) stock closed at 58.67 per share at the end of the most recent trading day (a -1.94% change compared to the prior day closing price) with a volume of 363.15K shares and market capitalization of 2.44B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 302 people. Axonics Modulation Technologies Inc. CEO is Raymond Wayne Cohen.

The one-year performance of Axonics Modulation Technologies Inc. stock is 70.52%, while year-to-date (YTD) performance is 17.53%. AXNX stock has a five-year performance of %. Its 52-week range is between 30 and 61.16, which gives AXNX stock a 52-week price range ratio of 92.01%

Axonics Modulation Technologies Inc. currently has a PE ratio of -40.20, a price-to-book (PB) ratio of 8.66, a price-to-sale (PS) ratio of 28.63, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -18.89%, a ROC of -29.73% and a ROE of -22.57%. The company’s profit margin is -46.99%, its EBITDA margin is -72.40%, and its revenue ttm is $85.24 Million , which makes it $2.05 revenue per share.

Of the last four earnings reports from Axonics Modulation Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.41 for the next earnings report. Axonics Modulation Technologies Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Axonics Modulation Technologies Inc. is Strong Buy (1.13), with a target price of $65.89, which is +12.31% compared to the current price. The earnings rating for Axonics Modulation Technologies Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Axonics Modulation Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Axonics Modulation Technologies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 8.87, ATR14 : 2.82, CCI20 : 17.42, Chaikin Money Flow : 0.17, MACD : 1.74, Money Flow Index : 54.93, ROC : -2.04, RSI : 52.05, STOCH (14,3) : 62.95, STOCH RSI : 0.00, UO : 65.10, Williams %R : -37.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Axonics Modulation Technologies Inc. in the last 12-months were: Alfred J. Ford (Option Excercise at a value of $49 700), Alfred J. Ford (Sold 41 967 shares of value $1 747 389 ), Danny L. Dearen (Option Excercise at a value of $217 927), Danny L. Dearen (Sold 182 508 shares of value $6 955 513 ), John Woock (Option Excercise at a value of $20 800), John Woock (Sold 33 810 shares of value $1 662 275 ), Juliet Tammenoms Bakker (Sold 13 953 shares of value $597 963 ), Raymond Wayne Cohen (Option Excercise at a value of $0), Raymond Wayne Cohen (Sold 166 469 shares of value $6 907 656 ), Rinda Sama (Option Excercise at a value of $456 585), Rinda Sama (Sold 154 162 shares of value $6 738 123 ), Robert E. Mcnamara (Sold 9 167 shares of value $475 133 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (87.50 %)
7 (87.50 %)
6 (85.71 %)
Moderate Buy
1 (12.50 %)
1 (12.50 %)
1 (14.29 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.13
Strong Buy
1.13
Strong Buy
1.14

Axonics Modulation Technologies Inc.

Axonics Modulation Technologies Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence.

CEO: Raymond Wayne Cohen

Telephone: +1 949 396-6322

Address: 26 Technology Drive, Irvine 92618, CA, US

Number of employees: 302

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

59%41%

Bearish Bullish

61%39%

Bearish Bullish

60%40%

News

Stocktwits